MUMBAI, Jul 5 (NNN-PTI) – India’s Panacea Biotec, received manufacturing license, to produce Russia’s COVID-19 vaccine, Sputnik V, the company said yesterday.
The license was granted by India’s drug regulator, pursuant to Panacea Biotec’s collaboration with Russian Direct Investment Fund, the sovereign wealth fund.
Earlier in May, the batches of vaccine were produced at Panacea Biotec’s facilities in India, and were shipped to the Gamaleya Centre in Russia for quality control, and they successfully cleared all quality parameters both in Russia as well as in India.
In Apr, Sputnik V was registered in India, under the emergency use authorisation procedure, and the inoculation in India, with the imported vaccines from Russia, started in May, by another Indian company, Dr Reddy’s Laboratories, who, too, has approval from the Russia’s sovereign wealth fund.– NNN-PTI
